广血清型肺炎球菌结合疫苗时代的社区获得性肺炎流行病学
韩国一项前瞻性队列研究纳入2669例≥19岁社区获得性肺炎(CAP)成人患者,肺炎球菌CAP占9.4%,年发病率18.3/10万;血清型以3型最常见,PCV13血清型占血清分型肺炎球菌CAP的46.7%,提示儿童PCV高接种率下成人疾病负担仍较高。
要点
- 肺炎球菌CAP占成人CAP的9.4%,年发病率18.3/10万。
- 血清分型肺炎球菌CAP中PCV13血清型占46.7%,3型最常见。
- 肺炎球菌CAP患者CURB-65评分更高(P=0.002)。
核心结论
- 儿童PCV高接种率下,韩国成人PCV13血清型肺炎球菌CAP疾病负担仍显著较高,尤其老年人。
研究设计与样本
- 2015年9月至2017年8月在4所大学医院开展前瞻性队列研究,纳入≥19岁社区获得性肺炎成人患者。
主要发现
- 2669例CAP患者中252例(9.4%)为肺炎球菌CAP。
- 全因CAP和肺炎球菌CAP年发病率分别为194.3例/10万和18.3例/10万。
- 107例(42.5%)通过培养或血清型特异性尿抗原检测确定血清型。
- PCV13血清型肺炎球菌CAP 50例(占血清分型肺炎球菌CAP 46.7%,占肺炎球菌CAP 19.8%)。
- PPSV23血清型肺炎球菌CAP 83例(占血清分型肺炎球菌CAP 77.6%,占肺炎球菌CAP 32.9%)。
临床怎么用
- 成人CAP经验性治疗和预防策略需考虑当地肺炎球菌血清型分布及PCV13覆盖血清型的持续疾病负担。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: South Korea has been providing 10-valent pneumococcal conjugate vaccine/(PCV10)/13-valent pneumococcal conjugate vaccine (PCV13) to children and 23-valent pneumococcal polysaccharide vaccine (PPSV23) to older adults as part of a national immunization program. METHODS: From September 2015 to August 2017, a prospective cohort study was conducted for adults aged ≥19 years with community-acquired pneumonia (CAP) at four university hospitals. All-cause and pneumococcal CAP incidence and mortality rates were evaluated on the basis of hospital catchment population. Serotype distribution of pneumococcal CAP was also evaluated. RESULTS: Among 2669 patients with CAP, 252 cases (9.4%) were pneumococcal CAP cases. The annual incidences of all-cause and pneumococcal CAP were 194.3 cases and 18.3 cases respectively, per 100,000 persons. Serotyped Streptococcus pneumoniae was identified in 107 cases (42.5%) through culture or a serotype-specific urinary antigen detection assay. Pneumococcal CAP caused by the PCV13 and PPSV23 serotypes were 50 cases (46.7% of serotyped pneumococcal CAP and 19.8% of pneumococcal CAP), and 83 cases (77.6% of serotyped pneumococcal CAP and 32.9% of pneumococcal CAP), respectively. The most prevalent serotype was 3 (n = 21, 19.6% of serotyped pneumococcal CAP), followed by 19A (n = 10, 9.3% of serotyped pneumococcal CAP) and 11A (n = 10, 9.3% of serotyped pneumococcal CAP). Compared with non-pneumococcal CAP patients, pneumococcal CAP patients were more likely to have a higher CURB-65 scores (P = 0.002). The overall 30-day mortality rate of pneumococcal CAP was higher than that of non-pneumococcal CAP (6.3% versus 5.6%; odds ratio [OR], 1.15; 95% confidence interval [CI], 0.67-1.96), but this trend was reversed in patients aged 65-74 years (4.2% versus 8.6%; OR, 0.47; 95% CI, 0.14-1.54). CONCLUSIONS: The disease burden of PCV13-serotype pneumococcal CAP remains significantly high in Korean adults, particularly among elderly people, even after a high uptake of pediatric PCVs.
引用
- Heo JY, Seo YB, Jeong HW, et al. Epidemiology of community-acquired pneumonia in the era of extended serotype-covering multivalent pneumococcal conjugate vaccines. Vaccine. 2020. PMID: 33164798. doi:10.1016/j.vaccine.2020.10.046
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。